TR200200301T2 - Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler - Google Patents

Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler

Info

Publication number
TR200200301T2
TR200200301T2 TR2002/00301T TR200200301T TR200200301T2 TR 200200301 T2 TR200200301 T2 TR 200200301T2 TR 2002/00301 T TR2002/00301 T TR 2002/00301T TR 200200301 T TR200200301 T TR 200200301T TR 200200301 T2 TR200200301 T2 TR 200200301T2
Authority
TR
Turkey
Prior art keywords
pathogenic bacteria
bifidobacteria
kill
diarrhea caused
present
Prior art date
Application number
TR2002/00301T
Other languages
English (en)
Inventor
Neeser Jean-Richard
Reniero Roberto
Rochat Florence
Servin Alain
Original Assignee
Societe Des Produits Nestle S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Des Produits Nestle S.A. filed Critical Societe Des Produits Nestle S.A.
Publication of TR200200301T2 publication Critical patent/TR200200301T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bu bulus patojenik bakterilerin yol açtigi ishali önlemekte kullanisli Bifidobacterium familyasindan yeni mikroorganizmalara iliskindir. Özel olarak bu bulus, söz geçen mikroorganizmalarin yenilebilir bir destek hazirlanmasi için kullanimina ve bunlari içeren bir bilesime iliskindir.
TR2002/00301T 1999-08-05 2000-07-26 Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler TR200200301T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99115502 1999-08-05

Publications (1)

Publication Number Publication Date
TR200200301T2 true TR200200301T2 (tr) 2004-12-21

Family

ID=8238733

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00301T TR200200301T2 (tr) 1999-08-05 2000-07-26 Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler

Country Status (12)

Country Link
US (2) US6926891B1 (tr)
EP (1) EP1206523B1 (tr)
CN (1) CN1186440C (tr)
AT (1) ATE425244T1 (tr)
AU (1) AU6160200A (tr)
BR (1) BR0012992A (tr)
CA (1) CA2380849C (tr)
DE (1) DE60041770D1 (tr)
ES (1) ES2321797T3 (tr)
HK (1) HK1046929A1 (tr)
TR (1) TR200200301T2 (tr)
WO (1) WO2001011015A1 (tr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
SE526711C2 (sv) * 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
EP1997880A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Breast milk bifidobacteria, compositions thereof, their use and a novel culture media to obtain them
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
US11690324B2 (en) 2011-05-05 2023-07-04 Steven J Terrell Apparatus for aerial tool configurations
US10492373B2 (en) 2011-05-05 2019-12-03 Steven J Terrell Apparatus for aerial tool configurations
US11382279B2 (en) 2011-05-05 2022-07-12 Steven J Terrell Apparatus for aerial tool configurations
US10492372B2 (en) 2011-05-05 2019-12-03 Steven J Terrell Apparatus for aerial tool configurations
US10798877B2 (en) 2011-05-05 2020-10-13 Steven J Terrell Apparatus for aerial tool configurations
US11330766B2 (en) 2011-05-05 2022-05-17 Steven J Terrell Apparatus for aerial tool configurations
AU2011385194B2 (en) * 2011-12-29 2015-03-05 Hill's Pet Nutrition, Inc. Compositions and methods for modifying gastrointestinal flora
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
WO2016129863A1 (en) 2015-02-12 2016-08-18 Samsung Electronics Co., Ltd. Payment processing method and electronic device supporting the same
KR102460459B1 (ko) 2015-02-27 2022-10-28 삼성전자주식회사 전자 장치를 이용한 카드 서비스 방법 및 장치
WO2016137277A1 (en) 2015-02-27 2016-09-01 Samsung Electronics Co., Ltd. Electronic device providing electronic payment function and operating method thereof
US10193700B2 (en) 2015-02-27 2019-01-29 Samsung Electronics Co., Ltd. Trust-zone-based end-to-end security
US10699274B2 (en) 2015-08-24 2020-06-30 Samsung Electronics Co., Ltd. Apparatus and method for secure electronic payment
US10846696B2 (en) 2015-08-24 2020-11-24 Samsung Electronics Co., Ltd. Apparatus and method for trusted execution environment based secure payment transactions
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
CA3174175A1 (en) * 2020-05-14 2021-11-18 Societe Des Produits Nestle S.A. Methods and compositions using serpin producing bacteria
CN114747534B (zh) * 2021-12-02 2023-04-18 中国农业大学 腹泻性大肠杆菌感染动物模型的构建方法及其应用
CN116121119B (zh) * 2022-11-30 2024-01-26 天津小薇生物科技有限公司 一种治疗腹泻的长双歧杆菌bc012及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
ES2111625T3 (es) 1992-07-06 1998-03-16 Nestle Sa Agente antigastritis.
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
IT1288119B1 (it) * 1996-06-28 1998-09-10 Renata Maria Anna Ve Cavaliere Composizioni dietetiche da utilizzare nell'alimentazione per via enterica

Also Published As

Publication number Publication date
CN1186440C (zh) 2005-01-26
BR0012992A (pt) 2002-05-07
AU6160200A (en) 2001-03-05
ES2321797T3 (es) 2009-06-12
EP1206523B1 (en) 2009-03-11
US7767430B2 (en) 2010-08-03
US20050260170A1 (en) 2005-11-24
DE60041770D1 (de) 2009-04-23
CA2380849C (en) 2010-06-29
US6926891B1 (en) 2005-08-09
CN1369005A (zh) 2002-09-11
ATE425244T1 (de) 2009-03-15
WO2001011015A1 (en) 2001-02-15
EP1206523A1 (en) 2002-05-22
HK1046929A1 (zh) 2003-01-30
CA2380849A1 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
TR200200301T2 (tr) Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
MY125941A (en) New lactobacillus strains preventing diarrhoea caused by pathogenic bacteria
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
ECSP055725A (es) Formulaciones nutricionales que contienen sustancias simbióticas
IL137093A0 (en) Methods of inactivating bacteria including bacterial spores
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
EA200201248A1 (ru) Применение lactobacillus casei в иммуностимуляторных пептидах
NO20031159D0 (no) Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjoner
CA2299937A1 (en) Synthetic medium for cultivating lactobacillus and bifidobacteria
DE60122881D1 (de) Nicht-lebensfähigen lactobacillus enthaltendes lebensmittelprodukt
DK1429808T3 (da) Sammensætning på fast form, der indeholder ikke patogene bakteriesporer af Bacillus-typen
BR0008920A (pt) Cepas de lactobacillus capazes de prevenirdiarréia causada por bactéria patogênica erotaviroses
DK1353681T3 (da) Bifidobakterier i stand til at modvirke diarré
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
EA200200704A1 (ru) Ослабленные микроорганизмы для лечения инфекции
ATE171072T1 (de) Rezeptor-konjugate zum targeting von arzneiwirkstoffen und anderen wirksubstanzen
KR950018031A (ko) 복합 올리고당 조성물